Researchers update white cane with navigation technology, robotics

Article

The white cane receives assistive updates to guide visually impaired users to destinations, making indoor navigation in unfamiliar locations easier and safer.

Researchers update white cane with navigation technology, robotics

New technology is on the horizon for people who use a white cane as a mobility aid.

A long-standing symbol of independence for those with visual impairments, the white cane has not been upgraded beyond surface improvements in nearly a century. Researchers are looking to update the device with technology that will guide the user to a specific location as well as avoid obstacles in their path.

The prototype features a colour 3D camera, sensors and a computer to detect, alert and guide users along their path. The motorized roller tip and audio cues will help users reach their destination.

Cang Ye, a professor at Virginia Commonwealth University's College of Engineering in Richmond, VA, in the United States reported that the goal of this technologically advanced white cane is to guide visually impaired people through unfamiliar indoor spaces. Apps and GPS are available to assist with outdoor navigation, but many people with visual impairments seek solutions for indoor guidance.

"You can kind of view this as a combination of a robotic guide dog and a cane," Ye said.

However, researchers still need to tweak the design to ensure the cane is light enough to use in day-to-day life. Additionally, the research team is exploring accuracy to ensure the user arrives at the correct location, despite slightly inaccurate turns or steps due to human error.

“While some cell phone apps can give people auditory navigation instructions, when going around a corner for example, how do you know you’ve turned just the right amount?” said Ye. “The rolling tip on our robotic cane can guide you to turn at just the right point and exactly the right number of degrees, whether it’s 15 degrees or 90. This version can also alert you to overhanging obstacles, which a standard white cane cannot."

Components of the robotic white cane are designed to endure long-term use, but the motorized tip will need to be replaced with some regularity.

While Dr Michael Chiang, director of the US National Eye Institute, reports that there is no way to predict when the new technology will hit the market, he said that the project is about “expanding opportunities for people with low vision,” and finding ways to “support the whole person.”

"We live in a very visual world," he pointed out. "Driving, reading, navigation  all rely on visual cues. If you can't see well, it's hard to use many of the devices that get us around in this world."

"We've never had so much technology available, and this research is an example of where we can match a human need with science and technology," Chiang said.

The study was funded by NEI and NIBI through grant EB018117.

Related Content: Gene Therapy | Retina | Cataract & Refractive

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.